NeuroVenti
Latest round
- Seed
Last raised
- Jun 2017
Total raised
- Undisclosed
Investors
- 2
About NeuroVenti
operates as a medical company developing therapeutic treatments for developmental mental disorders in patients with austism spectrum. In March 2024, NeuroVenti, Inc. NeuroVenti, Inc. specializes in the development of neuroprotective and therapeutic treatment to tackle intractable neurological conditions and brain diseases. It developed NV01-A02, which is a treatment for autism treatment and focusing on phase 2 clinical trials for autism spectrum disorder treatment while providing comprehensive non-clinical research services, including candidate substance discovery, preclinical consulting assessments for central nervous system disorders. The company’s products portfolio includes a wide range of solutions for brain development disorders and integrated brain disease treatments with various neurological disease models, in vivo and in vitro efficacy assessment systems, and mechanistic studies to deliver optimal treatment outcomes.
Who invested in NeuroVenti
2 investors across 1 round
See all investors in NeuroVenti
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 1, 2017
Amount
Undisclosed
Investors
Questions about NeuroVenti
Who invested in NeuroVenti?
NeuroVenti has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuroVenti raised?
NeuroVenti has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NeuroVenti last raise money?
NeuroVenti's most recent round on record is a Seed, in Jun 2017.
What does NeuroVenti do?
operates as a medical company developing therapeutic treatments for developmental mental disorders in patients with austism spectrum.
Where is NeuroVenti headquartered?
NeuroVenti is headquartered in Seoul, South Korea.
Which VCs invest in companies like NeuroVenti?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare specialists companies at NeuroVenti's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like NeuroVenti? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.